Activation of bombesin receptor subtype-3 influences activity of orexin neurons by both direct and indirect pathways.
The neuropeptides orexin A and orexin B (also known as hypocretin 1 and hypocretin 2), produced in lateral hypothalamic neurons, are critical regulators of feeding behavior, the reward system, and sleep/wake states. Orexin-producing neurons (orexin neurons) are regulated by various factors involved in regulation of energy homeostasis and sleep/wakefulness states. Bombesin receptor subtype 3 (BRS3) is an orphan receptor that might be implicated in energy homeostasis and is highly expressed in the hypothalamus. However, the neural pathway by which BRS3 regulates energy homeostasis is largely unknown. We examined whether BRS3 is involved in the regulation of orexin neurons. Using a calcium imaging method, we found that a selective BRS3 agonist [Ac-Phe-Trp-Ala-His-(tauBzl)-Nip-Gly-Arg-NH2] increased the intracellular calcium concentration of orexin neurons. However, intracellular recordings from slice preparations revealed that the BRS3 agonist hyperpolarized orexin neurons. The BRS3 agonist depolarized orexin neuron in the presence of tetrodotoxin. Moreover, in the presence of GABA receptor blockers, picrotoxin and CGP55845, the BRS3 agonist induced depolarization and increased firing frequency. Additionally, double-label in situ hybridization study revealed that Brs3 mRNA was expressed in almost all orexin neurons and many cells around these neurons. These findings suggest that the BRS3 agonist indirectly inhibited orexin neurons through GABAergic input and directly activated orexin neurons. Inhibition of activity of orexin neurons through BRS3 might be an important pathway for regulation of feeding and sleep/wake states. This pathway might serve as a novel target for the treatment of obesity.
Furutani
Naoki
N
Department of Molecular Neuroscience and Integrative Physiology, Faculty of Medicine, Kanazawa University, 13-1 Takaramachi, Kanazawa-shi, Ishikawa, 920-8640, Japan.
Hondo
Mari
M
Tsujino
Natsuko
N
Sakurai
Takeshi
T
D000818:Animals; D002118:Calcium / Q000378:metabolism; D007031:Hypothalamus / Q000166:cytology / Q000378:metabolism; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D009474:Neurons / Q000166:cytology / Q000378:metabolism*; D009479:Neuropeptides / Q000235:genetics / Q000378:metabolism*; D000068797:Orexins; D018408:Patch-Clamp Techniques; D018004:Receptors, Bombesin / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins; D018004:Receptors, Bombesin; C107120:bombesin receptor subtype 3; D005680:gamma-Aminobutyric Acid; D002118:Calcium
Regul Pept. 2000 Dec 22;96(1-2):45-51
11102651
Neuron. 2000 Sep;27(3):469-74
11055430
J Med Chem. 2003 May 8;46(10):1918-30
12723954
Neuroscience. 2003;120(2):309-24
12890504
Cell. 1999 Aug 6;98(3):365-76
10458611
J Endocrinol. 1999 Mar;160(3):R7-12
10077743
Biochemistry. 2002 Jul 16;41(28):8954-60
12102638
Eur J Biochem. 1992 Sep 1;208(2):405-10
1325907
Cell Metab. 2010 Feb 3;11(2):101-12
20096642
Neuron. 2003 Jun 5;38(5):701-13
12797956
Neuron. 2001 May;30(2):345-54
11394998
J Pept Sci. 2005 Mar;11(3):136-41
15635635
Genomics. 2004 Jul;84(1):139-46
15203211
J Neurosci. 2005 Aug 10;25(32):7459-69
16093397
J Pharmacol Exp Ther. 2008 Feb;324(2):463-74
18006692
Nat Med. 2000 Sep;6(9):991-7
10973318
Regul Pept. 2002 Mar 15;104(1-3):153-9
11830290
Biochem Biophys Res Commun. 2009 Sep 18;387(2):283-8
19580790
Physiol Behav. 1999 Jul;66(5):863-7
10405115
J Biol Chem. 1997 Oct 10;272(41):26062-71
9325344
Pharmacol Rev. 2008 Mar;60(1):1-42
18055507
Biochem Biophys Res Commun. 2003 Mar 28;303(1):120-9
12646175
Brain Res. 1997 Jul 11;762(1-2):165-72
9262170
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12150-5
16880388
Cell. 1998 Feb 20;92(4):573-85
9491897
Nature. 1997 Nov 13;390(6656):165-9
9367152
Cell. 1999 Aug 20;98(4):437-51
10481909